Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports the completion of a study evaluating the efficacy and safety of GSK2402968 in Duchenne muscular dystrophy, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• GSK2402968

Snippet

Sponsor: GlaxoSmithKline | Conditions: Muscular Dystrophies | Phase 3 | Status: COMPLETED | Results posted: 2019-01-28